Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks? Investors will be watching what Trump makes happen.

After a rapid rise, Eli Lilly needs only an 11% gain to hit $1 trillion in market value. Revenue is expected to rise 26% next ...

The medication instead dulled her urges for the cocaine and alcohol that caused her to plow her car into a tree, spiral into ...

Novo Nordisk A/S remains attractive with strong cash flow and robust pipeline. Click here to read why NVO stock is a Buy.

Taylor Frankie Paul kicked up buzz in a new Instagram post on Thursday, November 13. The racy influencer and reality TV star, ...

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling ...

Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh. Who is winning?

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Carol Saffran started taking Ozempic a year ago to regulate her blood sugar after other medications were ineffective. She was prediabetic, a condition in which blood sugar levels are higher than ...

Andy Richter opened up on his Dancing with the Stars weight loss, giving credit to GLP-1 medication, Zepbound, and the challenges behind using these drugs on Julianne Hough’s “The Morning After Show.” ...

Novo Nordisk and Eli Lilly deny partnership with Mangoceuticals for weight-loss drugs, causing Mangoceuticals' shares to ...